SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000945621-12-000183
Filing Date
2012-07-06
Accepted
2012-07-06 14:22:25
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 10 TO SCHEDULE 13D cti13da070512.htm SC 13D/A 66925
2 EXHIBIT A - LETTER TO PRESIDENT, CEO, BOD OF COMPANY ctiexha13da070512.htm EX-99 6846
  Complete submission text file 0000945621-12-000183.txt   75054
Mailing Address 4673 CHRISTOPHER PLACE DALLAS TX 75204
Business Address
AUSTIN JOSIAH T (Filed by) CIK: 0000932267 (see all company filings)

Type: SC 13D/A

Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Subject) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-81457 | Film No.: 12950320
SIC: 2836 Biological Products, (No Diagnostic Substances)